NGC-4865 - Adjuvant taxane therapy for women with early-st...
Guideline:Adjuvant taxane therapy for women with early-stage, invasive breast cancer. Measure Summary
NOTE: This guideline summary content is published by the National Guidelines Clearinghouse (NGC), in cooperation with the guideline authoring organization(s). For additional guideline resources, visit www.NGC.gov. Neither NGC or the original guideline authoring organization(s) approve of or endorse any product or service offered on this website. These NGC guideline summaries reside in the public domain and are displayed by GuidelineCentral.com as a convenient reference service for our customers visiting this website.
|
Bibliographic Source(s)
|
|
Identifying Information and Availability
Bibliographic Source(s)
|
|
Disclaimer
NGC Disclaimer
The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities. Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx. NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes. Readers with questions regarding guideline content are directed to contact the guideline developer. |
